HIV Mutation Detail Information

> A319T Search Result


Mutation Information
Mutation Site A319T
Mutation Type Amino acid level
Gene/Protein/Region Type Gp120
Country US
Literature Information
PubMed PMID 32156815
Disease HIV infection/AIDS
Published Year 2020
Journal mBio
Title Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants.
Author Martinez DR,Tu JJ,Kumar A,Mangold JF,Mangan RJ,Goswami R,Giorgi EE,Chen J,Mengual M,Douglas AO,Heimsath H,Saunders KO,Nicely NI,Eudailey J,Hernandez G,Morgan-Asiedu PK,Wiehe K,Haynes BF,Moody MA,LaBranche C,Montefiori DC,Gao F,Permar SR
Evidence In contrast, linear V3 epitope-specific IgG MAb H650099 obtained from transmitting woman 9105 had strong binding activity to V3.C and V3.B, and its binding activity was ablated against C-terminal V3 mutant peptides V3.B F317A A319K D322A, V3.B F317L A319T D322R, and V3.B F317A, suggesting that amino acid residue F317 was required for the binding activity (Fig. S5C).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation